Volume 18 - Issue 1 - January, 2006
Feature
Case Report
08/01/2008
Abdul Rashid, MD, Jorge Saucedo, MD, Thomas A. Hennebry, MD
Abdul Rashid, MD, Jorge Saucedo, MD, ...
Case Report. A 57-year-old woman underwent orthotopic cardiac transplant in 1997 secondary to nonischemic cardiomyopathy. Her symptoms of heart failure started in 1993 after a week of flu-like illness. A year later, she was diagnosed with...
Case Report. A 57-year-old woman underwent orthotopic cardiac transplant in 1997 secondary to nonischemic cardiomyopathy. Her symptoms of heart failure started in 1993 after a week of flu-like illness. A year later, she was diagnosed with...
Case Report. A 57-year-old woman...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Josef Veselka, MD, PhD, FESC, FSCAI and David Zem√°nek, MD
Josef Veselka, MD, PhD, FESC, FSCAI a...
Aneurysms of the ascending aorta are not uncommon in the catheterization laboratory. When encountered, they lead to problems catheterizing the left coronary artery in particular. We typically use catheters with a large bend in these cases...
Aneurysms of the ascending aorta are not uncommon in the catheterization laboratory. When encountered, they lead to problems catheterizing the left coronary artery in particular. We typically use catheters with a large bend in these cases...
Aneurysms of the ascending aorta...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Alan Zajarias, MD, Srihari Thanigaraj, MD, Megumi Taniuchi, MD, PhD
Alan Zajarias, MD, Srihari Thanigaraj...
Non-penetrating thoracic trauma has been associated with multiple structural and electrical cardiac injuries and complications with a mortality rate of up to 15%.1 The mechanisms for non-penetrating cardiac injury include: direct trauma,...
Non-penetrating thoracic trauma has been associated with multiple structural and electrical cardiac injuries and complications with a mortality rate of up to 15%.1 The mechanisms for non-penetrating cardiac injury include: direct trauma,...
Non-penetrating thoracic trauma...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
S. Anandaraja, MD, DM, Nitish Naik, MD, Kewal Talwar, MD
S. Anandaraja, MD, DM, Nitish Naik, M...
Percutaneous coronary interventions (PCI) are uncommon causes of coronary artery aneurysms (CAA). The incidence of CAA after percutaneous transluminal coronary angioplasty (PTCA) ranges from 3.9–5%,1,2,5–7 and after directional coronary...
Percutaneous coronary interventions (PCI) are uncommon causes of coronary artery aneurysms (CAA). The incidence of CAA after percutaneous transluminal coronary angioplasty (PTCA) ranges from 3.9–5%,1,2,5–7 and after directional coronary...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Speaker: Douglas Cavaye, MD and Michael Marin, MD
Moderators: Eberhard Zeitler, MD and Klemens Barth, MD
Panelists: Michael Lawrence-Brown, MD, Ernst Schneider, MD, Wolfgang Ritter, MD, Andrew Cragg, MD
Speaker: Douglas Cavaye, MD and Micha...
Wolfgang Ritter: We know that all devices have problems; for example, the VanGuard or the AneuRx® (Medtonic, Inc., Sunnyvale, California) can incur some disintegration 4 to 5 years postimplantation. With the Zenith device, the problem of late...
Wolfgang Ritter: We know that all devices have problems; for example, the VanGuard or the AneuRx® (Medtonic, Inc., Sunnyvale, California) can incur some disintegration 4 to 5 years postimplantation. With the Zenith device, the problem of late...
Wolfgang Ritter: We know that...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Moderator: Mike Cowley
Panelists: Scott Byrd and Philip Reid (Eli Lilly and Company); Renato DeRita (Centocor); John Spencer (Genentech)
Moderator: Mike Cowley
Panelists: Sco...
Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....
Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....
Philip Reid (Eli Lilly &...
08/01/2008
Journal of Invasive Cardiology
Column
Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC, FACA
Editor-in-Chief
Richard E. Shaw, PhD, FACC, FACA
Edit...
Dear Readers,
This issue of the Journal of Invasive Cardiology commences our 18th year of publication. There has been incredible growth in the field of invasive cardiology during 2005. Many of these growth areas have challenged the...
Dear Readers,
This issue of the Journal of Invasive Cardiology commences our 18th year of publication. There has been incredible growth in the field of invasive cardiology during 2005. Many of these growth areas have challenged the...
Dear Readers,
This issue of the...
08/01/2008
Journal of Invasive Cardiology
Insights
Commentary
08/01/2008
Frederick G.P. Welt, MD and Douglas W. Losordo, MD
Frederick G.P. Welt, MD and Douglas W...
Nearly two years after the widespread introduction of drug-eluting stents (DES) on the U.S. market, it is perhaps time to step back and evaluate the impact of this revolutionary technology on the practice of cardiology. Financial modeling has...
Nearly two years after the widespread introduction of drug-eluting stents (DES) on the U.S. market, it is perhaps time to step back and evaluate the impact of this revolutionary technology on the practice of cardiology. Financial modeling has...
Nearly two years after the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
*Stephen G. Worthley, MD, H.M. Omar Farouque, MD, James D. Cameron, MD, Ian T. Meredith, MD
*Stephen G. Worthley, MD, H.M. Omar F...
The development and even progression of coronary atherosclerotic lesions may occur without compromising the lumen in the early phases due to outward growth of the vessel wall; a concept known as “positive” or “outward” arterial remodeling.1...
The development and even progression of coronary atherosclerotic lesions may occur without compromising the lumen in the early phases due to outward growth of the vessel wall; a concept known as “positive” or “outward” arterial remodeling.1...
The development and even...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Alberto Hendler, MD, Avi Aronovich, MD, Edo Kaluski MD, Izhak Zyssman, MD, Yosef Gurevich, MD, Alex Blatt, MD, Meir Reicher, MD, Marina Leitman, MD, *Istvan Czuriga, MD, Zvi Vered MD, Ricardo Krakover, MD
Alberto Hendler, MD, Avi Aronovich, M...
Primary angioplasty has become the preferred therapeutic modality in patients with acute myocardial infarction (AMI). Despite a rapid and sustained restoration of flow through a previously occluded epicardial coronary artery, perfusion at the...
Primary angioplasty has become the preferred therapeutic modality in patients with acute myocardial infarction (AMI). Despite a rapid and sustained restoration of flow through a previously occluded epicardial coronary artery, perfusion at the...
Primary angioplasty has become...
08/01/2008
Journal of Invasive Cardiology
